Lifestyle Natural Medicines
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Average Price Target from Analysts
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has earned an average recommendation of “Hold” from the six research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sel
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has earned an average recommendation of “Hold” from the six research firms that are presently covering the company, MarketBeat Ratings reports. One… [+3388 chars]